Your browser doesn't support javascript.
loading
Refined Stratification Based on Baseline Concomitant Mutations and Longitudinal Circulating Tumor DNA Monitoring in Advanced EGFR-Mutant Lung Adenocarcinoma Under Gefitinib Treatment.
Duan, Jianchun; Xu, JiaChen; Wang, Zhijie; Bai, Hua; Cheng, Ying; An, Tongtong; Gao, Hongjun; Wang, Kai; Zhou, Qing; Hu, Yanping; Song, Yong; Ding, Cuimin; Peng, Feng; Liang, Li; Hu, Yi; Huang, Cheng; Zhou, Caicun; Shi, Yuankai; Han, Jiefei; Wang, Di; Tian, Yanhua; Yang, Zhenlin; Zhang, Li; Chuai, Shaokun; Ye, Junyi; Zhu, Guanshan; Zhao, Junhui; Wu, Yi-Long; Wang, Jie.
Affiliation
  • Duan J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xu J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang Z; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Bai H; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Cheng Y; Division of Thoracic Oncology, Jilin Cancer Hospital, Jilin Province Cancer Hospital, Changchun, People's Republic of China.
  • An T; Department of Thoracic Medical Oncology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Gao H; The 307th Hospital of Chinese People's Liberation Army, Beijing, People's Republic of China.
  • Wang K; Department of Respiratory Medicine, Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Hu Y; Department of Oncology, Hubei Cancer Hospital, Hubei, People's Republic of China.
  • Song Y; Nanjing General Hospital of Nanjing Military Command and PLA Bayi Hospital, Nanjing, People's Republic of China.
  • Ding C; Department of Respiratory Medicine, The Fourth Hospital of Hebei Medical University, Hebei, People's Republic of China.
  • Peng F; Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, People's Republic of China.
  • Liang L; Peking University Third Hospital, Beijing, People's Republic of China.
  • Hu Y; Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
  • Huang C; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Teaching Hospital of Fujian University of Traditional Chinese Medicine, Teaching Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
  • Zhou C; Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China.
  • Shi Y; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Han J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang D; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Tian Y; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Yang Z; Department of Thoracic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhang L; Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chuai S; Burning Rock Biotech, Guangdong, People's Republic of China.
  • Ye J; Burning Rock Biotech, Guangdong, People's Republic of China.
  • Zhu G; Amoy Diagnostics, Xiamen, People's Republic of China.
  • Zhao J; Department of Medical Oncology, Affiliated Hospital of Qinghai University, Qinghai, People's Republic of China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Wang J; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. Electronic address: zlhuxi@163
J Thorac Oncol ; 15(12): 1857-1870, 2020 12.
Article de En | MEDLINE | ID: mdl-32916309
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / ADN tumoral circulant / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Thorac Oncol Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / ADN tumoral circulant / Tumeurs du poumon Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: J Thorac Oncol Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique